News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
EraGen Biosciences Inc. Receives Health Canada Approval of Five MultiCode®-RTx Molecular Diagnostic Tests
September 22, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MADISON, Wis.--(BUSINESS WIRE)--EraGen Biosciences Inc. today announced it has received Health Canada approval to market five molecular testing products as in vitro diagnostics in the Canadian market.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
MORE ON THIS TOPIC
FDA
Prasad Under Probe for Promoting Workplace Toxicity, Staffers Say
February 27, 2026
·
2 min read
·
Tristan Manalac
Policy
FDA Policy Tracker 2026: One-Trial Drug Applications, Guidelines for Personalized Therapies
February 27, 2026
·
7 min read
·
Heather McKenzie
Regulatory
Makary Defends FDA’s Decision-Making Amid Contentious Rare Disease Rejections
February 27, 2026
·
2 min read
·
Tristan Manalac
Insights
ALS Advances Unite Patients and Pharma on Novel Targets, Biomarker Breakthroughs
February 26, 2026
·
1 min read
·
Jennifer Smith-Parker
